إعلان
إعلان

INAB

INAB logo

IN8bio, Inc. Common Stock

2.40
USD
برعاية
-0.10
-3.80%
٠٨ يناير, ١٥:٥٠ UTC -5
مغلق
exchange

بعد الإغلاق

2.38

-0.03
-1.21%

تقارير أرباح INAB

النسبة الإيجابية المفاجئة

INAB تفوق 10 من 17 آخر التقديرات.

59%

التقرير التالي

بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.69
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-18.82%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-42.50%

IN8bio, Inc. Common Stock earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, INAB reported earnings of -0.85 USD per share (EPS) for Q3 25, beating the estimate of -1.25 USD, resulting in a 32.25% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.69 USD, with revenue projected to reach -- USD, implying an نقصان of -18.82% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, IN8bio, Inc. Common Stock reported EPS of -$0.85, beating estimates by 32.25%, and revenue of $0.00, 0% as expectations.
The stock price moved down -6.63%, changed from $1.66 before the earnings release to $1.55 the day after.
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
Based on 4 المحللين, IN8bio, Inc. Common Stock is expected to report EPS of -$0.69 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان